These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2168550)

  • 1. Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.
    Shore SK; Bogart SL; Reddy EP
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6502-6. PubMed ID: 2168550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.
    Engelman A; Rosenberg N
    Mol Cell Biol; 1990 Aug; 10(8):4365-9. PubMed ID: 2164639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
    Allen PB; Morgan GJ; Wiedemann LM
    Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential.
    Franz WM; Berger P; Wang JY
    EMBO J; 1989 Jan; 8(1):137-47. PubMed ID: 2496972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.
    Rosson D; Reddy EP
    Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.
    Jackson P; Baltimore D
    EMBO J; 1989 Feb; 8(2):449-56. PubMed ID: 2542016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.
    Holland GD; Henkemeyer MJ; Kaehler DA; Hoffmann FM; Risser R
    J Virol; 1990 May; 64(5):2226-35. PubMed ID: 2157882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
    Engelman A; Rosenberg N
    J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures and activities of activated abl oncogenes.
    Risser R; Holland GD
    Curr Top Microbiol Immunol; 1989; 147():129-53. PubMed ID: 2695292
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
    Jackson PK; Paskind M; Baltimore D
    Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and origins of the HZ2-feline sarcoma virus.
    Bergold PJ; Wang JY; Hardy WD; Littau V; Johnson E; Besmer P
    Virology; 1987 Jun; 158(2):320-9. PubMed ID: 2884777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
    Mysliwiec T; Perego R; Kruh GD
    Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene.
    Shtivelman E; Lifshitz B; Gale RP; Roe BA; Canaani E
    Cell; 1986 Oct; 47(2):277-84. PubMed ID: 3021337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
    Reddy EP; Smith MJ; Srinivasan A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase.
    Prywes R; Foulkes JG; Baltimore D
    J Virol; 1985 Apr; 54(1):114-22. PubMed ID: 2983108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
    Rees-Jones RW; Goff SP
    J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of c-abl tyrosine kinase by its variable N-terminal amino acids.
    Wang JY
    Oncogene Res; 1988; 3(3):293-8. PubMed ID: 3144698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.
    Rosenbaum H; Harris AW; Bath ML; McNeall J; Webb E; Adams JM; Cory S
    EMBO J; 1990 Mar; 9(3):897-905. PubMed ID: 2155783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gene disruption of the endogenous c-abl locus by homologous recombination with DNA encoding a selectable fusion protein.
    Schwartzberg PL; Robertson EJ; Goff SP
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3210-4. PubMed ID: 2183226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of tyrosine kinase-coding region in v-abl oncogene by the expression of v-abl-encoded proteins in bacteria.
    Wang JY; Baltimore D
    J Biol Chem; 1985 Jan; 260(1):64-71. PubMed ID: 2981223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.